These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9930351

  • 1. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
    Byun J, Kim JM, Robbins PD, Kim S.
    Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J, Kim SH, Kim JM, Yu SS, Robbins PD, Yim J, Kim S.
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [Abstract] [Full Text] [Related]

  • 3. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
    Wildner O, Candotti F, Krecko EG, Xanthopoulos KG, Ramsey WJ, Blaese RM.
    Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
    [Abstract] [Full Text] [Related]

  • 4. Generation of mammalian cells stably expressing multiple genes at predetermined levels.
    Liu X, Constantinescu SN, Sun Y, Bogan JS, Hirsch D, Weinberg RA, Lodish HF.
    Anal Biochem; 2000 Apr 10; 280(1):20-8. PubMed ID: 10805516
    [Abstract] [Full Text] [Related]

  • 5. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
    Harries M, Phillipps N, Anderson R, Prentice G, Collins M.
    J Gene Med; 2000 Apr 10; 2(4):243-9. PubMed ID: 10953915
    [Abstract] [Full Text] [Related]

  • 6. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
    Xu L, Tsuji K, Mostowski H, Otsu M, Candotti F, Rosenberg AS.
    J Virol Methods; 2004 Jun 01; 118(1):61-7. PubMed ID: 15158069
    [Abstract] [Full Text] [Related]

  • 7. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells.
    Staal FJ, Bakker AQ, Verkuijlen M, van Oort E, Spits H.
    Cancer Gene Ther; 1996 Jun 01; 3(5):345-51. PubMed ID: 8894254
    [Abstract] [Full Text] [Related]

  • 8. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
    Hong Y, Yu SS, Kim JM, Lee K, Na YS, Whitley CB, Sugimoto Y, Kim S.
    J Gene Med; 2003 Jan 01; 5(1):18-29. PubMed ID: 12516048
    [Abstract] [Full Text] [Related]

  • 9. The Construction and Expression of Polycistronic Retroviral Vector Carrying Genes of TNF-alpha, IL-2 and NeoR.
    Lai GH, Tang ZY, Chen SS.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1998 Jan 01; 30(2):159-163. PubMed ID: 12174276
    [Abstract] [Full Text] [Related]

  • 10. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA, Mehaffey MG, Kaleko M, Nienhuis AW, Vanin EF.
    Blood Cells Mol Dis; 1998 Jun 01; 24(2):167-82. PubMed ID: 9642098
    [Abstract] [Full Text] [Related]

  • 11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 01; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 12. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
    Zhang RP, Yun L, Peng L, Lu B, Zhou Q, Wang H, Guo YJ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul 01; 22(4):420-2, 426. PubMed ID: 16805997
    [Abstract] [Full Text] [Related]

  • 13. [Efficient expression of multidrug resistance gene mdr1 in retroviral vector under control of an internal ribosome entry site].
    Fu J, Chen Z, Wang W.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Dec 01; 19(12):619-22. PubMed ID: 11263327
    [Abstract] [Full Text] [Related]

  • 14. Versatile retroviral vectors for potential use in gene therapy.
    Hawley RG, Lieu FH, Fong AZ, Hawley TS.
    Gene Ther; 1994 Mar 01; 1(2):136-8. PubMed ID: 7584069
    [Abstract] [Full Text] [Related]

  • 15. Development of a new bicistronic retroviral vector with strong IRES activity.
    Martin P, Albagli O, Poggi MC, Boulukos KE, Pognonec P.
    BMC Biotechnol; 2006 Jan 12; 6():4. PubMed ID: 16409632
    [Abstract] [Full Text] [Related]

  • 16. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats.
    Makarov SS, Olsen JC, Johnston WN, Schwab JH, Anderle SK, Brown RR, Haskill JS.
    Gene Ther; 1995 Aug 12; 2(6):424-8. PubMed ID: 7584118
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J, Ma L, Wei L.
    Chin Med J (Engl); 2001 Feb 12; 114(2):147-51. PubMed ID: 11780195
    [Abstract] [Full Text] [Related]

  • 18. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
    Douin V, Bornes S, Creancier L, Rochaix P, Favre G, Prats AC, Couderc B.
    BMC Biotechnol; 2004 Jul 27; 4():16. PubMed ID: 15279677
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting the performance of different long terminal repeats in the retroviral vector.
    Kim S, Lee K, Kim MD, Kang S, Joo CW, Kim JM, Kim SH, Yu SS, Kim S.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1017-22. PubMed ID: 16574062
    [Abstract] [Full Text] [Related]

  • 20. Retroviral bicistronic vectors.
    Pfützner W.
    Drug News Perspect; 2008 Nov 19; 21(9):473-80. PubMed ID: 19180265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.